Associate Director; M&A Analyst/Corporate Development


Corporate Development is a strategic function that encompasses strategy, portfolio management, and business development and licensing. This position will support us with evaluating business development and licensing opportunities and portfolio management-related initiatives. Working closely with the business development and licensing, commercial operations, Technical operations and R&D functions, the Senior Analyst will provide analysis and financial decision support to our various stakeholders.

The Senior Corporate Development Analyst will support the Corporate Development group in strategic investment and financial modeling and analysis, business planning, and presentation. This position will be responsible for developing forecasting analytics for various projects (in-licensing, acquisitions, pipeline assessments, process improvement) with respect to investment and return, capital budgets, and investment needs, as well as providing projected results and metrics in terms of return on investment, IRR, return on capital employed, and other relevant financial metrics.

Key Responsibilities

Prepare accurate and timely financial models and analyses in support of deals, portfolio projects, and investment opportunities under tight deadlines; create financial models incorporating research and analysis that shows leading indicators and key business projections and results.
Routinely support evaluation of business development, portfolio, and pipeline opportunities.
Help create presentations for senior management.
Manage multiple projects and competing priorities simultaneously
Develop and maintain relationships with various levels of personnel.
Engage with functional leaders to gather inputs.
Perform ad-hoc analysis and projects as required.
Assist as needed with building and maintaining dashboards and weekly/monthly reports for portfolio projects and deals under consideration.
Complete all company-based and job-related training as assigned by company within the required timeline.
Contribute to the best practices repository of the Corporate Development department.
Challenge processes and the status quo to drive improvements.

Job Requirements

BA/BS degree in Finance or equivalent. MBA and/or CPA certification preferred, not required.
Minimum years of experience: 5
Prior consulting, investment banking, corporate finance or related M&A experience-healthcare preferred.

Pharmaceutical Financial Modeling And Analysis Experience Essential.

Experience with risk adjustments as applied to investment decisions; discount rates, probability of technical and regulatory success, etc.
Demonstrate strong business acumen.
Technical expertise in finance, budgeting, and forecasting.
Knowledge of financial statement analysis and reporting.
Ability to build and maintain financial models.
Feel comfortable challenging business partners and make recommendations.
Critical thinking and problem solving skills.
Demonstrate strong attention to detail.
Must have excellent verbal communication and organizational skills.
Strong interpersonal skills including the ability to communicate effectively with individuals across all levels.
Ability to work in a fast paced, collaborative, team environment.
Commitment to quality and excellence, upholding the highest professional standards.
Effective presentation skills.
Advanced Microsoft Excel skills with the ability to provide meaningful analysis (toggles, project & deal scenarios).

qualified candidates should email resume and cover letter


Michael is a 1996 graduate from Rutgers, The State University of NJ where he majored in Political Science. After Rutgers, Michael spent a year in Israel studying and working with early stage tech companies. After returning to the US, Michael spent 5 years with The Princeton Review in Operations of their graduate level courses. In 2001, Michael joined a staffing company where he led his office in sales of IT consulting services. In 2003, Michael started TSE and quickly found a niche in Strategy Consulting. He has formed partnerships with some of the leading consultancies in the areas of portfolio strategy, commercial assessment, market assess, payer strategy and operational effectiveness. Michael has helped consultancies and client side companies make key hires. In addition to recruiting, Michael helped Rutgers University create their Center for Innovative Ventures of Emerging Technologies and served as an Entrepreneur-in-Residence and Sounding Board Member for 5 years. He continues to stay active in the field of higher learning helping students of the sciences think about careers in the pharmaceutical industry.